HLI:NYSEHoulihan Lokey, Inc. Analysis

Houlihan Lokey (HLI) is trading at $143.16, just above its 20‑day SMA of 142.7 but still below the 50‑day (149.6) and 200‑day (170.8) averages, indicating short‑term momentum yet longer‑term weakness. The 14‑day RSI sits at 49, signaling a neutral stance, while the MACD histogram turned positive, giving a modest bullish signal. The stock’s PE of 22.5 sits well above the capital‑markets industry average of 17.1, suggesting a premium valuation, although the forward PE of 15.2 points to expected earnings acceleration. Volatility over the past 30 days is elevated at roughly 30 % and beta is sub‑1 (≈0.84), implying the share moves less than the broader market but can swing sharply. The dividend yield of 1.96 % with a payout ratio under 40 % and a net cash position of $1.2 B versus $0.5 B of debt underpins cash‑flow stability. Recent news highlights the addition of Dave Buscaglia as Managing Director of the Business Services Group, a hire that could broaden fee‑based revenue streams. The support level at $133.83 and resistance at $153.18 give a clear trading range, with current price comfortably above support. Decreasing volume trends suggest waning short‑term enthusiasm, which could temper near‑term upside.
Analyst consensus (8 contributors) projects a median price of $169, and the Fear & Greed Index at 92.13 signals “extreme greed,” reflecting bullish market sentiment despite a bearish technical trend. Given the mix of over‑valuation markers, solid profitability (ROE ≈ 18 %) and a sustainable dividend, the stock appears fairly priced for investors with a medium‑term horizon, while the downside risk remains limited by its strong balance sheet and low leverage.